Joff Wild, IAM Magazine | 24 Jul 2014 | Read Blog
Richard Lloyd, Intellectual Asset Management | 22 Jul 2014 | Read Blog
Jack Ellis, IAM Magazine | 22 Jul 2014 | Read Blog
While hundreds of nominations are
received, only a select few individuals
are chosen for induction into the
IP Hall of Fame each year. The
achievements of this year’s inductees
confirm their status as thought
leaders in their respective fields
Merck Sharp & Dohme Corp (MSD) owns a patent protecting the application of the drug finasteride for the treatment of androgenic alopecia. MSD initiated infringement proceedings in 2012 against Mylan, which was marketing a generic finasteride product. The District Court of The Hague recently ruled on this dispute.
The European Patent Office's central limitation procedure has shown its potential to disrupt infringement and validity hearings in the UK courts after the UK Court of Appeal agreed to adjourn an appeal in the ongoing dispute between Apple and Samsung.
Thomson Reuters is the world's leading provider of intellectual property solutions. Our offerings are used by professionals across the IP lifecycle to develop, maintain and extract maximum value from their intellectual assets. Visit our Intellectual Property Solutions website to see how we can support your needs across the IP lifecycle.